Showing results 4 to 9 of 9
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2013 | ||||
2017 | 172 | |||
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma Journal:Clinical Cancer Research | 2018 | 50 | ||
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy Journal:Cancer Chemotherapy and Pharmacology | 2012 | 71 | ||
Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma Proceeding/Conference:European Journal of Cancer Supplements | 2009 | 138 | ||
2016 |